Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma
Treatment Of Children Over The Age Of 1 Year With Unresectable Localized Neuroblastoma Without MYCN Amplification
Sponsor: Children's Cancer and Leukaemia Group
This PHASE3 trial investigates Neuroblastoma and is currently completed. Children's Cancer and Leukaemia Group leads this study, which shows 6 recorded versions since 2000 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Dec 2000
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Children's Cancer and Leukaemia Group
- Societe Internationale d'Oncologie Pediatrique
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Cologne, Germany , Genoa, Italy , Ghent, Belgium , Gothenburg, Sweden , Lausanne, Switzerland , Lisbon, Portugal , Odense, Denmark , Oslo, Norway , Southampton, United Kingdom , Toulouse, France and 2 more locations